Literature DB >> 21323980

Changes in quality of life during biofeedback for people with puborectalis dyssynergia: generic and disease-specific measures.

Fen-Fen Zhu1, Zheng Lin, Lin Lin, Mei-Feng Wang.   

Abstract

AIM: The aim of the study was to evaluate the changes in symptoms and quality of life in people with puborectalis dyssynergia after biofeedback by using Short Form-36 and Patient Assessment of Constipation Quality of Life Questionnaire.
BACKGROUND: Biofeedback is an effective treatment in clinical symptoms for puborectalis dyssynergia. However, little is known about the degree of the variation in the quality of life for these people after biofeedback.
METHOD: Thirty-six people with puborectalis dyssynergia were studied between June 2006 and March 2008. A bowel symptom record, a generic quality of life measure - the Short Form-36 and a disease-specific measure - the Patient Assessment of Constipation Quality of Life Questionnaire were recorded before and after biofeedback.
FINDINGS: Thirty-one people rated their satisfaction with behavioural treatment as 'major' or 'fair' and substantial symptom improvements occurred. Before treatment, seven of Short Form-36 subscales (except bodily pain) were significantly lower in people with puborectalis dyssynergia than those in healthy individuals. Following treatment, all subcategories except general health showed improvement surpassing pretreatment baseline values and equalling those for normal. The total Patient Assessment of Constipation Quality of Life Questionnaire score also dramatically improved as did all subscales. The nurses continually encouraged the participants, increased participants' motivation and got good outcomes.
CONCLUSION: Patient-centred functional status outcomes measured by general and disease-specific instruments give critical data, from which to inform patient management. The nurses should give psycho-social support and increase the participants' motivation during training.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21323980     DOI: 10.1111/j.1365-2648.2010.05593.x

Source DB:  PubMed          Journal:  J Adv Nurs        ISSN: 0309-2402            Impact factor:   3.187


  5 in total

1.  MR defecography: a diagnostic test for the evaluation of pelvic floor motion in patients with dyssynergic defecation after biofeedback therapy.

Authors:  Afsaneh Nikjooy; Nader Maroufi; Ismaeil Ebrahimi Takamjani; Homayoun Hadizdeh Kharazi; Bahar Mahjoubi; Rasoul Azizi; Hamid Haghani
Journal:  Med J Islam Repub Iran       Date:  2015-03-09

2.  Rectal Hyposensitivity Is Associated With a Defecatory Disorder But Not Delayed Colon Transit Time in a Functional Constipation Population.

Authors:  Ting Yu; Dong Qian; Yongping Zheng; Ya Jiang; Ping Wu; Lin Lin
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

3.  The Effects of Cognitive Behavioral Therapy with Biofeedback Therapy on the Quality of Life, Anxiety, Depression and Somatic Symptoms in Patients with Dyssynergic Defecation: A Randomized Controlled Trial.

Authors:  Afsaneh Nikjooy; Aniss Khoshlahjeh Sedgh; Bahar Mahjoubi; Rezvan Mirzaei; Mahdyieh Naziri; Parnian Mirbehresi
Journal:  Med J Islam Repub Iran       Date:  2022-07-05

4.  Primary Care Management of Chronic Constipation in Asia: The ANMA Chronic Constipation Tool.

Authors:  Kok-Ann Gwee; Uday C Ghoshal; Sutep Gonlachanvit; Andrew Seng Boon Chua; Seung-Jae Myung; Shaman Rajindrajith; Tanisa Patcharatrakul; Myung-Gyu Choi; Justin C Y Wu; Min-Hu Chen; Xiao-Rong Gong; Ching-Liang Lu; Chien-Lin Chen; Nitesh Pratap; Philip Abraham; Xiao-Hua Hou; Meiyun Ke; Jane D Ricaforte-Campos; Ari Fahrial Syam; Murdani Abdullah
Journal:  J Neurogastroenterol Motil       Date:  2013-04-16       Impact factor: 4.924

Review 5.  The effect of biofeedback interventions on pain, overall symptoms, quality of life and physiological parameters in patients with pelvic pain : A systematic review.

Authors:  Barbara Wagner; Margarete Steiner; Dominikus Franz Xaver Huber; Richard Crevenna
Journal:  Wien Klin Wochenschr       Date:  2021-03-22       Impact factor: 1.704

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.